Comments
Loading...
Enanta Pharma (NASDAQ:ENTA) Stock Quotes, Forecast and News Summary
Enanta Pharma Stock (NASDAQ: ENTA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Enanta Pharma (ENTA) stock?
You can purchase shares of Enanta Pharma (NASDAQ:ENTA) through any online brokerage.
Who are Enanta Pharma (ENTA) competitors?
Other companies in Enanta Pharma’s space includes: Zura Bio (NASDAQ:ZURA), Cabaletta Bio (NASDAQ:CABA), Monopar Therapeutics (NASDAQ:MNPR), Aligos Therapeutics (NASDAQ:ALGS) and Atossa Therapeutics (NASDAQ:ATOS).
What is the forecast, or price target, for Enanta Pharma (ENTA) stock?
Enanta Pharma has a consensus price target of $36.36.
What is the current price for Enanta Pharma (ENTA)?
The stock price for Enanta Pharma (NASDAQ: ENTA) is $6.11 last updated December 23, 2024 at 9:37 AM EST.
Does Enanta Pharma (ENTA) pay a dividend?
There are no upcoming dividends for Enanta Pharma.
When is Enanta Pharma (NASDAQ:ENTA) reporting earnings?
Enanta Pharma’s Q1 earnings are confirmed for Wednesday, February 5, 2025.
Is Enanta Pharma (ENTA) going to split?
There is no upcoming split for Enanta Pharma.
What sector and industry does Enanta Pharma (ENTA) operate in?
Enanta Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.